LUNAI BIOWORKS EXECUTES $20M STRATEGIC TRANSACTION AT FIXED $1.50 CONVERSION, ACQUIRING BBB DELIVERY PLATFORM FOR CNS ALZHEIMER'S THERAPIES WITH BROAD CNS DELIVERY APPLICATIONS
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.